Nasdaq
Idorsia announces half year results for 2017 - successful start of new biopharmaceutical company
03-08-2017
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Idorsia Pharmaceuticals Ltd. via GlobeNewswire
HUG#2125154